Le Journal
Divers
Medicare premiums to jump 10% heading into 2026
Most Medicare enrollees will face premiums that are 10% higher next year, creating budget anxiety for millions of seniors. Older adults and people with disabilities will pay almost $203 per month in 2026 for their Medicare Part B premium, the Trump administration said late Friday. That’s about 10% higher than the $185 per month that Medicare beneficiaries pay this year. Read the rest…
Divers
Five Free Agents the Mets Should Target This Winter
On the heels of an immensely disappointing season – one that saw a team with lofty expectations miss out on the playoffs on the final day of the year – the Mets have their work cut out for them this offseason. With beloved closer Edwin Díaz and franchise home run leader Pete Alonso entering free agency, and a pitching staff that faltered down the stretch, the team faces a glaring need across the roster: a frontline…
Divers
STAT+: Pfizer closes $10 billion Metsera deal
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning! If you’re still wondering “What the heck happened with Moderna?” the latest episode of the video series STATus Report spells it out quite nicely. Also, a KFF poll shows 1 in 8 Americans have used a GLP-1 by now, Kura wins FDA approval for its AML drug, and more. The need-to-know this…
Divers
Judge says he’ll approve opioid settlement with OxyContin maker Purdue and Sackler family
NEW YORK — A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma’s latest deal to settle thousands of lawsuits over the toll of opioids that includes some money for thousands of victims of the epidemic. The deal overseen by U.S. Bankruptcy Judge Sean Lane would require members of the Sackler family who own the company to contribute up to $7 billion and give up ownership. The…
Opinion: Celebrating a new, faster path to gene-editing medicines on demand
Divers
Opinion: Celebrating a new, faster path to gene-editing medicines on demand
In May, news broke of a biomedical first: the on-demand design and clinical use of a personalized gene editor for a baby boy born with a rare, severe genetic condition. At the STAT Summit in October, the child’s treating physician from the Children’s Hospital of Philadelphia (CHOP) and the lead on developing the gene editor for him shared the stage with him and his parents. The video of a happily squirming 1-year-old brought tears of joy to the eyes of many. A sobering reminder of the long road ahead toward more such videos was shared in these pages by Celena Lozano, whose son lives with a no less rare and severe genetic condition called PURA syndrome. Concerned over false hope inadvertently created by exuberant media coverage of the success story, she wrote, “families of the rare disease community deserve to have a better understanding of when their child might be next.”Read the rest…
Divers
Advocates decry intersex exceptions in trans health bans
The scars have been there as long as Emory Hufbauer can remember. When Hufbauer was a baby, doctors performed an operation that Hufbauer describes generally as one that took away their fertility and their ability to produce their own hormones; they also describe it emphatically as intersex genital mutilation. Read the rest…
Divers
STAT+: Up and down the ladder: The latest comings and goings
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week. This time around, we note that Strand Therapeutics…
Comment on The Drab Five: A Look at the 5 Biggest Mistakes of the Raiders’ Offseason by Raiderro
Divers
Comment on The Drab Five: A Look at the 5 Biggest Mistakes of the Raiders’ Offseason by Raiderro
Although the Darnold situation is still the worse, I must say the failure to resign Chaisson is up there too. Dude had a great year under Leonard, our best coach, and he could’ve been had for peanuts
Divers
Comment on Raiders Insider Raises Interesting Speculation on Patrick Graham’s Future in Las Vegas by Raiderro
Yes the Tom Brady connection is paying off dividends. Meanwhile Seattle & New England ditched these 2 clowns how are they doing?
Divers
NIH abruptly places outspoken critic of Trump administration on leave
A vocal critic of Trump administration actions at the National Institutes of Health was abruptly placed on administrative leave this week. Jenna Norton, a program official at the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK), was told Thursday she was being immediately placed on administrative leave with full pay. The email notifying her of the move, which she shared with STAT, did not…
Espace publicitaire · 728×90
Divers
STAT+: Pharmalittle: We’re reading about a Merck acquisition, Novo facing shareholder backlash, and more
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up, but already we have identified a few activities, such as firing up the leaf blower, promenading with the official mascots, and catching up on our growing reading list. There will also be time for another listening party,…
Divers
More Americans use weight loss drugs like Ozempic than live in Texas
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. The Ig Nobel awards just happened, but I’d like to pitch this study — which found that a man’s shouts will scare gulls away from food — for next year’s consideration.Read the rest…